Wedbush Starts Cerulean Pharma (CERU) at Outperform

Go back to Wedbush Starts Cerulean Pharma (CERU) at Outperform

Leerink Swann Starts Cerulean Pharma (CERU) at Outperform

May 6, 2014 9:11 AM EDT

Leerink Swann initiated coverage on Cerulean Pharma (NASDAQ: CERU) with an Outperform rating and a price target of $13.00.

For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.

Shares of Cerulean Pharma closed at $6.75 yesterday.

... More

JMP Securities Starts Cerulean Pharma (CERU) at Market Outperform

May 6, 2014 6:38 AM EDT

JMP Securities initiated coverage on Cerulean Pharma (NASDAQ: CERU) with a Market Outperform rating and a price target of $14.00.

For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.

Shares of Cerulean Pharma closed at $6.75 yesterday.

... More

Canaccord Genuity Starts Cerulean Pharma (CERU) at Buy

May 6, 2014 6:37 AM EDT

Canaccord Genuity initiates coverage on Cerulean Pharma (NASDAQ: CERU) with a Buy rating and a price target of $11.00.

For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.

Shares of Cerulean Pharma closed at $6.75 yesterday.

... More